CANADA PENSION PLAN INVESTMENT BOARD - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
CANADA PENSION PLAN INVESTMENT BOARD ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2019$294,000
-71.1%
23,113
-11.8%
0.00%
-50.0%
Q1 2019$1,017,000
-3.9%
26,212
-49.6%
0.00%0.0%
Q4 2018$1,058,000
-38.8%
52,000
+37.9%
0.00%
-33.3%
Q3 2018$1,729,000
-33.3%
37,700
-1.0%
0.00%
-25.0%
Q1 2018$2,593,000
-25.3%
38,100
+8.5%
0.00%
-42.9%
Q4 2017$3,470,000
+50.2%
35,100
+81.9%
0.01%
+40.0%
Q3 2017$2,311,000
-38.4%
19,300
-55.0%
0.01%
-44.4%
Q2 2017$3,749,000
+134.3%
42,900
-0.2%
0.01%
+125.0%
Q1 2017$1,600,000
+144.6%
43,000
+101.9%
0.00%
+100.0%
Q4 2016$654,000
-41.6%
21,300
+27.5%
0.00%
-50.0%
Q3 2016$1,120,000
+244.6%
16,700
+53.2%
0.00%
+300.0%
Q2 2016$325,000
+65.0%
10,900
+62.7%
0.00%0.0%
Q1 2016$197,000
-35.6%
6,700
+71.8%
0.00%0.0%
Q4 2015$306,000
+125.0%
3,900
+116.7%
0.00%0.0%
Q3 2015$136,000
-61.1%
1,800
-40.0%
0.00%0.0%
Q2 2015$350,000
-62.0%
3,000
-23.1%
0.00%
-66.7%
Q1 2015$921,0003,9000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2017
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders